{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:29:42Z","timestamp":1782199782914,"version":"3.54.5"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22fk0108604h1002"],"award-info":[{"award-number":["22fk0108604h1002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Lascufloxacin (LSFX) achieves concentrations in epithelial lining fluid (ELF) that are more than 15 times higher than those in the bloodstream, making it a promising candidate for respiratory and otorhinolaryngological infections. These concentrations were replicated using the Hollow-Fiber Infection Model and demonstrated bactericidal efficacy of LSFX against levofloxacin-sensitive and -resistant <jats:italic>Streptococcus pneumoniae<\/jats:italic>. The study confirms that LSFX\u2019s elevated concentration in ELF plays a significant role in its bactericidal activity.<\/jats:p>","DOI":"10.1038\/s41429-025-00826-7","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T02:56:03Z","timestamp":1746586563000},"page":"388-391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of lung epithelial lining fluid concentrations of lascufloxacin against Streptococcus pneumoniae in a hollow-fiber infection model"],"prefix":"10.1038","volume":"78","author":[{"given":"Haruka Nakagawa","family":"Kamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Kasama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitaka","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakaze","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"826_CR1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02208-18","volume":"63","author":"K Ohya","year":"2019","unstructured":"Ohya K, Takano J, Manita S. In vitro mechanistic study of the distribution of lascufloxacin into epithelial lining fluid. Antimicrob Agents Chemother. 2019;63:e02208\u201318. https:\/\/doi.org\/10.1128\/AAC.02208-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"826_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jiac.2019.09.010","volume":"26","author":"K Totsuka","year":"2020","unstructured":"Totsuka K, Sesoko S, Fukase H, Ikushima I, Odajima M, Niwayama Y. Pharmacokinetic study of lascufloxacin in non-elderly healthy men and elderly men. J Infect Chemother. 2020;26:231\u20139. https:\/\/doi.org\/10.1016\/j.jiac.2019.09.010.","journal-title":"J Infect Chemother"},{"key":"826_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.coph.2017.09.011","volume":"36","author":"GL Drusano","year":"2017","unstructured":"Drusano GL. Pre-clinical in vitro infection models. Curr Opin Pharm. 2017;36:100\u20136. https:\/\/doi.org\/10.1016\/j.coph.2017.09.011.","journal-title":"Curr Opin Pharm"},{"key":"826_CR4","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1093\/jac\/dkab160","volume":"76","author":"Z Sadouki","year":"2021","unstructured":"Sadouki Z, McHugh TD, Aarnoutse R, Ortiz Canseco J, Darlow C, Hope W, et al. Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting. J Antimicrob Chemother. 2021;76:2252\u20139. https:\/\/doi.org\/10.1093\/jac\/dkab160.","journal-title":"J Antimicrob Chemother"},{"key":"826_CR5","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jiac.2019.03.008","volume":"25","author":"K Tateda","year":"2019","unstructured":"Tateda K, Ohno A, Ishii Y, Murakami H, Yamaguchi K. Levofloxacin surveillance group. Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: A longitudinal analysis from 1994 to 2016. J Infect Chemother. 2019;25:594\u2013604. https:\/\/doi.org\/10.1016\/j.jiac.2019.03.008.","journal-title":"J Infect Chemother"},{"key":"826_CR6","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, M100-Ed34. Wayne PA. CLSI; 2024."},{"key":"826_CR7","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M07-Ed12. Wayne PA. CLSI; 2024."},{"key":"826_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02169-17","volume":"62","author":"H Furuie","year":"2018","unstructured":"Furuie H, Tanioka S, Shimizu K, Manita S, Nishimura M, Yoshida H. Intrapulmonary pharmacokinetics of lascufloxacin in healthy adult volunteers. Antimicrob Agents Chemother. 2018;62:e02169\u201317. https:\/\/doi.org\/10.1128\/AAC.02169-17.","journal-title":"Antimicrob Agents Chemother"},{"key":"826_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/jac\/dkac376","volume":"78","author":"YT Endo","year":"2022","unstructured":"Endo YT, Aoki K, Hamada M, Kamura HN, Ishii Y, Tateda K. Full-length whole-genome sequencing analysis of emerged meropenem-resistant mutants during long-term in vitro exposure to meropenem for borderline meropenem-susceptible carbapenemase-producing and non-carbapenemase-producing Enterobacterales. J Antimicrob Chemother. 2022;78:209\u201315. https:\/\/doi.org\/10.1093\/jac\/dkac376.","journal-title":"J Antimicrob Chemother"},{"key":"826_CR10","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.watres.2010.12.007","volume":"45","author":"PZ Culfaz","year":"2011","unstructured":"Culfaz PZ, Wessling M, Lammertink RG. Fouling behavior of microstructured hollow fiber membranes in submerged and aerated filtrations. Water Res. 2011;45:1865\u201371. https:\/\/doi.org\/10.1016\/j.watres.2010.12.007.","journal-title":"Water Res"},{"key":"826_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10047-020-01214-8","volume":"24","author":"D Onichimowski","year":"2021","unstructured":"Onichimowski D, Nosek K, Zi\u00f3\u0142kowski H, Jaroszewski J, Pawlos A, Czuczwar M. Adsorption of vancomycin, gentamycin, ciprofloxacin and tygecycline on the filters in continuous renal replacement therapy circuits: in full blood in vitro study. J Artif Organs. 2021;24:65\u201373. https:\/\/doi.org\/10.1007\/s10047-020-01214-8.","journal-title":"J Artif Organs"}],"updated-by":[{"DOI":"10.1038\/s41429-025-00837-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000}}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00826-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00826-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00826-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:58:08Z","timestamp":1750139888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00826-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1038\/s41429-025-00826-7","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article the Conflict of Interest statement was incorrectly published as \u201cThe authors declare no competing interests.\u201d but should have been \u201cThis study was funded by KYORIN Pharmaceutical Co., Ltd.\u201c. The original article has been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41429-025-00837-4","URL":"https:\/\/doi.org\/10.1038\/s41429-025-00837-4","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was funded by KYORIN Pharmaceutical Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}